BusinessGritstone Oncology and Arbutus Biopharma Announce LNP Technology Licensing Agreement to Develop Novel RNA-Based Personalized Neoantigen Immunotherapies for Cancer PatientsBy Nasdaq OMXOct 18, 2017, 12:01 PM UTC
BusinessVital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With WebcastBy Nasdaq OMXOct 18, 2017, 12:01 PM UTC
BusinessMyriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza® (olaparib) in Metastatic Breast CancerBy Nasdaq OMXOct 18, 2017, 11:00 AM UTC
BusinessCrown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds at the American Association for Cancer Research’s International Conference on Molecular Targets and Cancer TherapeuticsBy Nasdaq OMXOct 17, 2017, 1:51 PM UTC
BusinessNeothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health CompanyBy Nasdaq OMXOct 17, 2017, 12:02 PM UTC
BusinessKraig Biocraft Laboratories Gains Critical Approval from Vietnamese Governmental MinistryBy Nasdaq OMXOct 17, 2017, 10:05 AM UTC
BusinessCytoDyn Announces Investment Community Conference Call for October 19, 2017By Nasdaq OMXOct 17, 2017, 10:00 AM UTC
BusinessImmune Design Announces Positive FDA Feedback on Phase 3 Clinical Trial Design for CMB305 in Synovial Sarcoma PatientsBy Nasdaq OMXOct 16, 2017, 8:16 PM UTC
